Once upon a time, words like “acid” and “peel” were scary medical jargon you’d only hear inside a dermatologist’s clinic. Skincare meant a trusty cold cream or maybe your mom’s age-old ubtan recipe — not chemical exfoliants and potent retinoids in fancy dropper bottles. But somewhere along the way, science stepped into our bathroom shelves, and “derm-grade” skincare broke free from the prescription pad. What was once clinical, niche, and carefully monitored is now a billion-dollar industry in India alone — powered by savvy, self-educated consumers who want visible results, not just promises. This is the story of how once-prescription-only actives went mainstream, why they’re now an everyday beauty staple, and how India’s booming cosmeceuticals market is racing ahead — blurring the lines between the doctor’s clinic and your vanity shelf.
Unless you’re a seasoned chemist, the complex ingredient lists and percentage claims on your skincare bottles probably leave you scratching your head. It’s easy to wonder — while a 20% concentration of one active might be a game-changer for your skin, why do you only need a mere 2% of another to see results?
Your bathroom cabinet today probably looks more like a dermatologist’s trolley than your grandma’s cold cream collection. Bottles and tubes now proudly flaunt names and ingredients that were once reserved only for prescriptions — for acne, pigmentation, and other targeted skin issues. But now, acids, retinoids, and peels are sold over the counter in sleek dropper bottles and bright foaming cleansers — an undeniable part of many people’s skincare regimes.
“Skincare wasn’t always a buzzword. Growing up, I saw women either hiding their skin issues or just living with them — and clinical skincare? That was reserved for celebrities or people who could afford dermatologist visits. But today, something powerful has shifted. Science has walked into our homes, and self-care is no longer a luxury. It’s a necessity,” says Dr. Preeti Seth, Founder and Mentor at Pachouli Aesthetics and Wellness.
Somewhere between the dermatologist’s clinic and your local beauty aisle, a line has blurred. Who decides how much acid is too much? Who checks that your brightening soap won’t leave you with burns? And when does a beauty product quietly become a drug that really should be prescribed?
“Most patients who come to us with chemical burns today have used these products unsupervised,” says Dr. Anuya Gupta, a Delhi-based dermatologist. “They buy them online because an influencer recommended it — but they don’t know the right concentration or layering technique.”
The rise of active-based products like AHAs, retinols, and peptides being available over-the-counter has changed everything. As Dr. Seth puts it, “People now ask, ‘What’s in this?’ before they ask, ‘What does it cost?’ That’s awareness. That’s evolution. We have moved from hiding flaws to healing skin. From relying on filters to actually fixing what’s beneath.”
This is the story of how your bathroom shelf turned into a mini chemistry lab — and why, despite the promise of “professional results,” no one seems to be truly keeping watch.
A generation ago, the idea of putting acid on your face would have sounded bizarre. Hydroxy acids, retinoids, and potent skin-lightening agents like kojic acid were once tightly controlled — administered only under the watchful eye of a qualified skin specialist. They were powerful tools used for targeted concerns like stubborn acne, hyperpigmentation, or severe photo-ageing — not for casual daily scrubbing.
But the late 1990s and early 2000s saw the dawn of the “cosmeceutical” — a term coined to describe cosmetic products infused with active pharmaceutical ingredients. It’s not a legally regulated category; it’s marketing gold. Brands quickly realised that consumers wanted more than just moisture and fragrance — they wanted visible, measurable results.
And results sell. The global cosmeceuticals market alone was valued at about US$ 52.5 billion in 2022, according to Grand View Research, and it’s projected to grow at a healthy 8.8% CAGR through 2030. The appetite for “derm-grade” skincare is showing no signs of slowing down — and India is right at the heart of this shift.
According to IMARC Group, India’s skincare market alone is expected to double from around US$ 6.5 billion in 2022 to nearly US$ 13 billion by 2027, expanding at a robust 12% CAGR. The wider beauty and personal care segment could cross US$ 30 billion, with once-clinical actives like acids and retinoids becoming everyday shelf staples. A 2023 report by RedSeer and Peak XV highlights how young urban consumers, especially in Tier 1 and Tier 2 cities, are driving this surge — trading basic moisturisers for “problem-solving” serums, chemical peels, and exfoliators that promise salon-like results from the comfort of home.
As Dr. Diivyaa Agarwal, Head Business Lead & MarComm at Pachouli Aesthetics and Wellness, puts it, “Skincare today is no longer about superficial maintenance — it’s about deep, result-driven transformation. Over the years, I’ve witnessed a major shift: consumers are more aware, more informed, and more assertive in their skincare choices. With easy access to information through Google, AI, podcasts, and social media, people seek active, potent solutions that work.”
This dramatic shift has created a multi-billion-dollar opportunity for both local and international brands. Homegrown Indian labels, global giants, and nimble D2C startups are all tapping into this surge. From affordable acid toners to premium “dermatologist-formulated” retinol serums, the range of products now available on shelves — and online — is vast.
“Clinical skincare becoming mainstream is a sign that India is ready — ready to blend tradition with science, beauty with well-being, and affordability with effectiveness,” Dr. Seth says. “I’m so glad to be part of this change.”
What’s truly powerful is that skincare has become gender-neutral. “Both men and women — especially those with economic independence — are no longer willing to settle for generic products. They demand efficacy, science, and real impact,” adds Dr. Agarwal. “We recognised this shift early. The launch of our Pachouli Cosmeceutical Range was not just a product line — it was a movement. It is our way of empowering individuals with accessible clinical skincare — bringing global standards into Indian homes.”
E-commerce has played a huge role too. Statista reports that nearly 35% of global beauty consumers now buy skincare online, including from cross-border sellers, opening up the Indian market to international trends while giving domestic brands a global stage. Many Indian cosmeceutical players are not just catering to local demand but also exporting to Southeast Asia, the Middle East, and Africa — leveraging India’s cost-effective manufacturing strengths and access to quality ingredients.
In India, the Drugs and Cosmetics Act, 1940, and the Drugs and Cosmetics Rules, 1945, define what is a “cosmetic” versus a “drug.” The Central Drugs Standard Control Organisation (CDSCO) oversees compliance.
In practice:
Retinol (milder) is allowed in cosmetics up to certain limits — but tretinoin, its prescription-strength cousin, is a Schedule H drug in India.
Hydroquinone, a skin lightener, is banned for over-the-counter use in the EU and restricted in India for unsupervised use because of risks like ochronosis.
Salicylic acid is allowed up to 2% in leave-on products in most regions; higher strengths require medical supervision.
But here’s the catch: there is no harmonised global standard. What’s cosmetic in Korea might be medicinal in the EU. And with thousands of small brands and imported products, enforcement is patchy.
One problem is that “cosmeceutical” isn’t a legal category. “It’s a marketing term — not a scientific or regulatory one,” explains Dr. Marina Peredo, MD, a Long Island, N.Y., dermatologist. This means brands can play in that grey area.
Rather than stifling the category, stronger guidelines and more transparent labelling can actually build trust and help the market grow sustainably. More informed consumers mean fewer side effects and better brand loyalty — a win-win for the industry.
Skincare has drastically changed — actives and layering have become synonymous with modern self-care. India’s vibrant beauty and personal care market — supported by digital awareness, influencer-led marketing, and rapid urbanisation — shows that this is not just a passing trend but a long-term shift in how people invest in their skin.
Dr. Agarwal sums it up best: “We believe this is not just a trend — it is the future of skincare: inclusive, intentional, and intelligently driven.”
For India’s manufacturers, formulators, exporters, and ingredient suppliers, this is a space brimming with opportunity — but it’s also a space where quality, education, and ethical innovation will make the real difference. After all, a booming industry is best sustained when its consumers feel safe, informed, and confident about what they’re putting on their skin.
You must be logged in to post a comment.
Stay ahead in the dynamic world of trade and commerce with India Business & Trade's weekly newsletter.